MRI study links glymphatic system dysfunction to idiopathic intracranial hypertension | Optometry Times - Clinical News

Published on January 29, 2026
This research is part of the IIH Research and Treatment Initiative, a new philanthropy-funded program launched at Mass General Brigham.
Continue reading on website
Other news

FDA approves Yuvezzi (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% for presbyopia | Optometry Times - Clinical News

January 29, 2026
Formerly known as Brimochol PF, the dual-agent eye drop is now the first and only of its kind for the treatment of presbyopia in adults.

Cognitive-Behavioral Therapy May Help Address Mental Health Conditions in IIH, Study Suggests

January 30, 2026
A small study found that most patients with IIH who suffer from a mental health disorder favored anxiety management as a therapeutic focus. Therefore, the authors suggest that “CBT protocols for illness anxiety, generalized anxiety and adjustment disorders would be particularly relevant.” Photo: Alison Bozung, OD. Click image to enlarge. Reports show that close to half (45%)